← Leaderboards
Douglas A Marchuk
Duke University
$20,574,970
Attributed
$26,770,926
Total exposure
19
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,709,821 · 20
By mechanism
P01$17,300,454 · 6
R01$13,724,835 · 7
R44$3,287,712 · 1
T32$2,658,375 · 1
U54$1,058,371 · 1
P30$749,800 · 1
Top collaborators
- Issam A Awad13 shared
- Scott R Floyd4 shared
- Lisa J Mckerracher3 shared
- Rebecca A Stockton3 shared
- Donald C Lo1 shared
Most similar at Duke University
Same institution · by research overlap
- Michael Barry Kastan$65,974,699
- Gerard C Blobe$15,421,046
- Charles Michael Cotten$5,917,623
- Lee Zou$13,956,280
- Micah A. Luftig$19,856,384
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeGenesBlood VesselsMolecularBrainMouse ModelPathogenesisGeneticMutationOperative Surgical ProceduresLesionSignal TransductionEventEndothelial CellsStrokeSomatic MutationClinically RelevantProteinsGene MutationCerebral Cavernous MalformationsSignal PathwayBaseLeadHemorrhage
Grant awards (98)
Developmental Origins of the Sturge Weber Syndrome Somatic Mutation$201,875
R21 · FY2025 · HD · contact PI
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis$1,249,844
P01 · FY2024 · NS · contact PI
Somatic mutation(s) and cellular changes in CCM pathogenesis$321,343
P01 · FY2024 · NS · contact PI
Administrative Core$35,177
P01 · FY2024 · NS · contact PI
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis$1,295,444
P01 · FY2023 · NS · contact PI
Somatic mutation(s) and cellular changes in CCM pathogenesis$415,446
P01 · FY2023 · NS · contact PI
Administrative Core$36,265
P01 · FY2023 · NS · contact PI
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis$1,303,254
P01 · FY2022 · NS · contact PI
Novel Targets for Stroke Intervention - Gene Discovery for Modulators of Infarction$638,289
R01 · FY2022 · NS · contact PI
Somatic mutation(s) and cellular changes in CCM pathogenesis$331,345
P01 · FY2022 · NS · contact PI
Administrative Core$36,271
P01 · FY2022 · NS · contact PI
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis$1,310,712
P01 · FY2021 · NS · contact PI
Novel Targets for Stroke Intervention - Gene Discovery for Modulators of Infarction$638,289
R01 · FY2021 · NS · contact PI
Somatic mutation(s) and cellular changes in CCM pathogenesis$331,316
P01 · FY2021 · NS · contact PI
Administrative Core$36,267
P01 · FY2021 · NS · contact PI
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis$1,353,471
P01 · FY2020 · NS · contact PI
Novel Targets for Stroke Intervention - Gene Discovery for Modulators of Infarction$638,289
R01 · FY2020 · NS · contact PI
Somatic mutation(s) and cellular changes in CCM pathogenesis$337,398
P01 · FY2020 · NS · contact PI
Administrative Core$49,553
P01 · FY2020 · NS · contact PI
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis$1,260,831
P01 · FY2019 · NS · contact PI
Novel Targets for Stroke Intervention - Gene Discovery for Modulators of Infarction$639,088
R01 · FY2019 · NS · contact PI
Molecular genetic alterations contributing to CCM pathogenesis$295,125
P01 · FY2019 · NS · contact PI
Administrative Core$48,538
P01 · FY2019 · NS · contact PI
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis$1,268,359
P01 · FY2018 · NS · contact PI
Novel Targets for Stroke Intervention - Gene Discovery for Modulators of Infarction$650,198
R01 · FY2018 · NS · contact PI
Molecular genetic alterations contributing to CCM pathogenesis$299,961
P01 · FY2018 · NS · contact PI
Administrative Core$49,522
P01 · FY2018 · NS · contact PI
Development of BA-1049 for treatment of cerebral cavernous malformation$1,576,432
R44 · FY2017 · NS
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis$1,275,792
P01 · FY2017 · NS · contact PI
Molecular genetic alterations contributing to CCM pathogenesis$316,936
P01 · FY2017 · NS · contact PI
Administrative Core$52,516
P01 · FY2017 · NS · contact PI
Development of BA-1049 for treatment of cerebral cavernous malformation$1,430,655
R44 · FY2016 · NS
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis$1,282,511
P01 · FY2016 · NS · contact PI
Rock Inhibition as Therapy for Cerebral Cavernous Malformation$433,569
R01 · FY2016 · NS
Molecular genetic alterations contributing to CCM pathogenesis$309,217
P01 · FY2016 · NS · contact PI
Development of BA-1049 for treatment of cerebral cavernous malformation$280,625
R44 · FY2016 · NS
Functional Characterization of the GNAQ somatic mutation causing Sturge Weber syndrome$238,500
R21 · FY2016 · NS · contact PI
Administrative Core$51,410
P01 · FY2016 · NS · contact PI
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis$1,338,677
P01 · FY2015 · NS · contact PI
Rock Inhibition as Therapy for Cerebral Cavernous Malformation$455,117
R01 · FY2015 · NS
Molecular genetic alterations contributing to CCM pathogenesis$314,822
P01 · FY2015 · NS · contact PI
Functional Characterization of the GNAQ somatic mutation causing Sturge Weber syndrome$198,128
R21 · FY2015 · NS · contact PI
Administrative Core$52,470
P01 · FY2015 · NS · contact PI
Rock Inhibition as Therapy for Cerebral Cavernous Malformation$473,253
R01 · FY2014 · NS
Genetics Training Grant$432,052
T32 · FY2014 · GM · contact PI
Rock Inhibition as Therapy for Cerebral Cavernous Malformation$447,296
R01 · FY2013 · NS
Genetics Training Grant$446,546
T32 · FY2013 · GM · contact PI
Innovative approaches to gauge progression of Sturge-Weber Syndrome$201,682
U54 · FY2013 · NS · contact PI
Rock Inhibition as Therapy for Cerebral Cavernous Malformation$459,797
R01 · FY2012 · NS
Genesis and Progression of Cerebral Cavernous Malformations$457,386
R01 · FY2012 · NS · contact PI
Genetics Training Grant$446,546
T32 · FY2012 · GM · contact PI
Natural genetic variation regulating infarct volume$386,100
R01 · FY2012 · HL · contact PI
Genesis and Progression of Cerebral Cavernous Malformations$476,791
R01 · FY2011 · NS · contact PI
Genetics Training Grant$441,880
T32 · FY2011 · GM · contact PI
Natural genetic variation regulating infarct volume$390,000
R01 · FY2011 · HL · contact PI
Innovative approaches to gauge progression of Sturge-Weber Syndrome$277,465
U54 · FY2011 · NS · contact PI
Genesis and Progression of Cerebral Cavernous Malformations$479,794
R01 · FY2010 · NS · contact PI
Genetics Training Grant$437,344
T32 · FY2010 · GM · contact PI
Identification of genetics modifiers of heart diease$390,000
R01 · FY2010 · HL · contact PI
Natural genetic variation regulating infarct volume$390,000
R01 · FY2010 · HL · contact PI
Innovative approaches to gauge progression of Sturge-Weber Syndrome$283,183
U54 · FY2010 · NS · contact PI
Genesis and Progression of Cerebral Cavernous Malformations$88,629
R01 · FY2010 · NS · contact PI
Genesis and Progression of Cerebral Cavernous Malformations$484,559
R01 · FY2009 · NS · contact PI
Genetics Training Grant-Year 26$454,007
T32 · FY2009 · GM · contact PI
Identification of genetic modifiers of heart disease$390,000
R01 · FY2009 · HL · contact PI
Natural genetic variation regulating infarct volume$390,000
R01 · FY2009 · HL · contact PI
Innovative approaches to gauge progression of Sturge-Weber Syndrome$296,041
U54 · FY2009 · NS · contact PI
Identification of genetic modifiers of heart disease$390,000
R01 · FY2008 · HL · contact PI
Identification of genetic modifiers of heart disease$389,479
R01 · FY2007 · HL · contact PI
Gene Discovery for Cerebral Cavernous Malformations$314,735
R01 · FY2006 · NS · contact PI
Gene Discovery for Cerebral Cavernous Malformations$322,310
R01 · FY2005 · NS
Gene Discovery for Cerebral Cavernous Malformations$322,310
R01 · FY2004 · NS
GENETICS OF HEREDITARY HEMORRHAGIC TELANGIECTASIA$308,000
R01 · FY2004 · HL
Gene Discovery for Cerebral Cavernous Malformations$322,310
R01 · FY2003 · NS
GENETICS OF HEREDITARY HEMORRHAGIC TELANGIECTASIA$308,000
R01 · FY2003 · HL
Gene Discovery for Cerebral Cavernous Malformations$70,538
R01 · FY2003 · NS
Gene Discovery for Cerebral Cavernous Malformations$334,865
R01 · FY2002 · NS
GENETICS OF HEREDITARY HEMORRHAGIC TELANGIECTASIA$308,000
R01 · FY2002 · HL
Core--Genome facility$187,450
P30 · FY2002 · CA
MODEL OF HEREDIT HEMORRHAG TELANGIECTASIA: MR MICROSCOPY OF ALK 1 KNOCKOUT MICE$0
P41 · FY2002 · RR
MODEL OF HEREDIT HEMORRHAG TELANGIECTASIA: MR MICROSCOPY OF ALK 1 KNOCKOUT MICE$0
P41 · FY2002 · RR
MOLECULAR STUDIES OF DOMINANT AUTOSOMAL SPASTIC PARAPLEGIA (SPG)$0
P01 · FY2002 · NS
MOLECULAR STUDIES OF DOMINANT AUTOSOMAL SPASTIC PARAPLEGIA (SPG)$0
P01 · FY2002 · NS
GENETICS OF HEREDITARY HEMORRHAGIC TELANGIECTASIA$308,000
R01 · FY2001 · HL
MODEL OF HEREDIT HEMORRHAG TELANGIECTASIA: MR MICROSCOPY OF ALK 1 KNOCKOUT MICE$288,015
P41 · FY2001 · RR
MOLECULAR STUDIES OF DOMINANT AUTOSOMAL SPASTIC PARAPLEGIA (SPG)$207,281
P01 · FY2001 · NS
Core--Genome facility$187,450
P30 · FY2001 · CA
Core--Genome facility$187,450
P30 · FY2001 · CA
Core--Genome facility$187,450
P30 · FY2001 · CA
MOLECULAR STUDIES OF DOMINANT AUTOSOMAL SPASTIC PARAPLEGIA (SPG)$0
P01 · FY2001 · NS
MODEL OF HEREDIT HEMORRHAG TELANGIECTASIA: MR MICROSCOPY OF ALK 1 KNOCKOUT MICE$0
P41 · FY2001 · RR
Core--Genome facility$0
P30 · FY2001 · CA
GENETICS OF HEREDITARY HEMORRHAGIC TELANGIECTASIA$229,844
R01 · FY2000 · HL
MOLECULAR STUDIES OF DOMINANT AUTOSOMAL SPASTIC PARAPLEGIA (SPG)$226,099
P01 · FY2000 · NS
MOLECULAR STUDIES OF DOMINANT AUTOSOMAL SPASTIC PARAPLEGIA (SPG)$207,281
P01 · FY2000 · NS
MODEL OF HEREDIT HEMORRHAG TELANGIECTASIA: MR MICROSCOPY OF ALK 1 KNOCKOUT MICE$3,756
P41 · FY2000 · RR
Core--Genome facility$0
P30 · FY2000 · CA
Core--Genome facility$0
P30 · FY2000 · CA